MRC2 and colorectal cancer: Analysis of expression data from the CCLE is consistent with the IHC staining and gene-expression analysis of primary tumors (Fig. 1; Supplementary Fig. S1), showing significantly higher MRC2 expression in both STS and bone sarcoma cell lines compared with breast or colorectal cancer cell lines (Fig. 2A).